Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
Vascular & Endovascular: A new FDA approval for Medtronic | Survival on the rise among high-risk PE patients
Thursday, June 16, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: Vascular & Endovascular

Medtronic gains FDA approval for new DCB compatible with 0.018” guidewires

The drug-coated balloon was approved to treat patients with peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries

READ MORE >
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.
Share on Twitter Share on Facebook Share on Linkedin

Medtronic gains FDA approval for new DCB compatible with 0.018” guidewires

Share on Twitter Share on Facebook Share on Linkedin
Medtronic has received FDA approval for its IN.PACT 018 Paclitaxel-Coated Percutaneous Transluminal Angioplasty (PTA) Balloon Catheter. FDA clears new drug eluting balloon, drug-coated balloon.
The drug-coated balloon was approved to treat patients with peripheral arterial disease (PAD) in the superficial femoral and popliteal arteries
READ MORE >

Survival on the rise among high-risk pulmonary embolism patients

The study's authors examined data from more than 1.4 million patients, noting that pulmonary embolism response teams appear to be playing a significant role. 

READ MORE >
Survival on the rise among high-risk pulmonary embolism patients.
Share on Twitter Share on Facebook Share on Linkedin

Survival on the rise among high-risk pulmonary embolism patients

Share on Twitter Share on Facebook Share on Linkedin
Survival on the rise among high-risk pulmonary embolism patients.
The study's authors examined data from more than 1.4 million patients, noting that pulmonary embolism response teams appear to be playing a significant role. 
READ MORE >

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

There have been five reported incidents so far, including one patient injury.

READ MORE >
Dragonfly OpStar Imaging Catheter FDA recall May 2022
Share on Twitter Share on Facebook Share on Linkedin

FDA announces Class I recall of 4,800 imaging catheters due to risk of vascular injury

Share on Twitter Share on Facebook Share on Linkedin
Dragonfly OpStar Imaging Catheter FDA recall May 2022
There have been five reported incidents so far, including one patient injury.
READ MORE >

VIDEO: What interventional cardiologists need to perform pulmonary embolism thrombectomy

There is a national trend where cardiology is increasingly being called in to help with PE response teams (PERT) at hospitals. Terry Bowers from Beaumont explains what skills interventional cardiologists need for PE procedures.

READ MORE >
Terry Bowers, MD, director of vascular medicine at Beaumont Hospital, Royal Oak, Michigan, and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the skillset needed for pulmonary embolism (PE) thrombectomy procedures. #PERT #PE
Share on Twitter Share on Facebook Share on Linkedin

VIDEO: What interventional cardiologists need to perform pulmonary embolism thrombectomy

Share on Twitter Share on Facebook Share on Linkedin
Terry Bowers, MD, director of vascular medicine at Beaumont Hospital, Royal Oak, Michigan, and national co-chair of the Pulmonary Embolism Research Collaborative (PERC), explains the skillset needed for pulmonary embolism (PE) thrombectomy procedures. #PERT #PE
There is a national trend where cardiology is increasingly being called in to help with PE response teams (PERT) at hospitals. Terry Bowers from Beaumont explains what skills interventional cardiologists need for PE procedures.
READ MORE >

Open AAA repair linked to better long-term outcomes than EVAR

However, the authors noted, 30-day survival is significantly higher after EVAR than open AAA repair.  

READ MORE >
Abdominal aortic aneurysm (AAA)
Share on Twitter Share on Facebook Share on Linkedin

Open AAA repair linked to better long-term outcomes than EVAR

Share on Twitter Share on Facebook Share on Linkedin
Abdominal aortic aneurysm (AAA)
However, the authors noted, 30-day survival is significantly higher after EVAR than open AAA repair.  
READ MORE >

Empagliflozin may reverse vascular aging, lower CVD risk

The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.

READ MORE >
heart_body_blood_bloodvessel.jpg
Share on Twitter Share on Facebook Share on Linkedin

Empagliflozin may reverse vascular aging, lower CVD risk

Share on Twitter Share on Facebook Share on Linkedin
heart_body_blood_bloodvessel.jpg
The SGLT2 inhibitor is already known as an effective medication for both type 2 diabetes and heart failure.
READ MORE >

New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque. 

READ MORE >
Example of ultrasound-assisted laser arterial plaque removal, which might be developed into a new type of less traumatic atherectomy system.Image courtesy of Rohit Singh.
Share on Twitter Share on Facebook Share on Linkedin

New atherosclerosis treatment uses ultrasound-assisted lasers to break down plaque

Share on Twitter Share on Facebook Share on Linkedin
Example of ultrasound-assisted laser arterial plaque removal, which might be developed into a new type of less traumatic atherectomy system.Image courtesy of Rohit Singh.
The new technique is still in the development stage, but early research suggests it could provide clinicians with a new treatment option for breaking down arterial plaque. 
READ MORE >

RAAS inhibitors lower risk of aneurysm rupture among patients with high blood pressure

Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.

READ MORE >
Brain
Share on Twitter Share on Facebook Share on Linkedin

RAAS inhibitors lower risk of aneurysm rupture among patients with high blood pressure

Share on Twitter Share on Facebook Share on Linkedin
Brain
Researchers also noted that uncontrolled hypertension, exposure to second-hand smoke and untreated type 2 diabetes were all associated with a greater rupture risk.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme